Effects of endoscopic variceal ligation on survival in cirrhotic patients-Reference-Cited by-同舟云学术

Effects of endoscopic variceal ligation on survival in cirrhotic patients

Published:2023-07-25 Issue:6 Volume: Page:84-88
ISSN:1682-8658
Container-title:Experimental and Clinical Gastroenterology
language:
Short-container-title:jour

Author:

Samartsev V. A.¹,Protasov V. V.²,Lozhkina N. V.³

Affiliation:

1. Perm State Medical University n. a. E. A. Wagner of the Ministry of Health of the Russian Federation; City Clinical Hospital No.4

2. Regional Clinical Hospital named after Academician Wagner E. A

3. Perm State Medical University n. a. E. A. Wagner of the Ministry of Health of the Russian Federation

Abstract

Acute esophageal variceal bleeding (AEVB) is a serious complication of liver cirrhosis and is leading cause in hepatic failure and death. Endoscopic variceal ligation (EVL) is the mainstream treatment mode for management of esophageal varices. The aim of the study was to investigate survival rate in urgent - elective (secondary AEVB prophylaxis) and elective (primary AEVB prophylaxis) groups. This article intends to investigate regimens and long-term outcomes of primary or secondary prophylaxis of AEVB in 161 cirrhotic patients. A new risk factor for cirrhosis decompensation stratification is proposed. It is based on a number of necessary EVL bands to achieve sustained (at least 12 months) varix elimination. This study showed that survival rate was strongly inversely dependent on this newly proposed varix elimination index.

Publisher

LLC Global Media Technology

Subject

Gastroenterology,Hepatology

Reference15 articles.

1. Mokdad A. A., Lopez A. D., Shahraz S., Lozano R., et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. 2014 Sep 18;12:145. doi: 10.1186/s12916-014-0145-y.

2. D’Amico G., Garcia-Tsao G., Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006 Jan;44(1):217-31. doi: 10.1016/j.jhep.2005.10.013.

3. Fleming K.M., Aithal G. P., Card T. R., West J. All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study. Liver Int. 2012 Jan;32(1):79-84. doi: 10.1111/j.1478-3231.2011.02517.x.

4. de Franchis R., Bosch J., Garcia-Tsao G., Reiberger T., et al. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022 Apr;76(4):959-974. doi: 10.1016/j.jhep.2021.12.022.

5. Abraldes J.G., Villanueva C., Bañares R., Aracil C., et al. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol. 2008 Feb;48(2):229-36. doi: 10.1016/j.jhep.2007.10.008.